Royce & Associates’s Kindred Biosciences, Inc. KIN Stock Holding History

Royce & Associates’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-126,000	Closed	-$1.09M	–	1278
2018 Q1	$1.09M	Hold	126,000	–	–	0.01%	955
2017 Q4	$1.19M	Hold	126,000	–	–	0.01%	943
2017 Q3	$989K	Hold	126,000	–	–	0.01%	968
2017 Q2	$1.08M	Hold	126,000	–	–	0.01%	954
2017 Q1	$888K	Sell	126,000 -22,000	-15%	-$138K	0.01%	996
2016 Q4	$629K	Hold	148,000	–	–	﹤0.01%	990
2016 Q3	$736K	Hold	148,000	–	–	﹤0.01%	958
2016 Q2	$524K	Hold	148,000	–	–	﹤0.01%	983
2016 Q1	$511K	Buy	148,000 +58,000	+64%	+$205K	﹤0.01%	983
2015 Q4	$306K	Buy	+90,000	New	+$417K	﹤0.01%	1053

Other funds holding KIN

Park West Asset Management San Francisco, California $1.13B AUM 47.25% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

General American Investors New York $1.51B AUM 37.94% 1-Year Est. Return

Pacific View Asset Management San Francisco, California $20.8M AUM 20.08% 1-Year Est. Return